Vella 1995.
| Methods | Trial design: randomised trial |
| Participants | Participants: 30 Meang age: not stated Inclusion criteria: not stated Exclusion criteria: not stated Setting: not stated Timing: not stated |
| Interventions | Group 1: goserelin versus Group 2: goserelin + premarin (conjugated oestrogens) 1.25 mg |
| Outcomes |
|
| Notes | Intention‐to‐treat analysis: not stated Sample size calculation: not stated Funding: not stated This abstract did not contain enough information to make a proper decision about in‐/exclusion. |
DPMA: depot medroxyprogesterone acetate GnRHa: gonadotropin‐releasing hormone analogues IM: intramuscular LA: leuprolide acetate